SIMPOSIO AFI LIVE WEBINAR “WORKSHOP: DIGITAL TECHNOLOGY FOR CLINICAL RESEARCH: A DATA-DRIVEN APPROACH TO STUDY PLANNING, MANAGEMENT AND OVERSIGHT”
The COVID-19 pandemic emphasized the pivotal role of technology in accelerating safe clinical trial execution. Companies with robust tools and processes for clinical operations which enabled agility and collaboration were successful in adjusting to complexities resulting from the pandemic. Now, more and more organizations are reshaping their clinical operations with improved analytics and risk-based quality management (RBQM) approaches, to drive efficiency and scale without compromising data integrity or patient safety.
This webinar explored the ways data and technology are being used to support and drive today’s trials, and how these innovations are permanently changing the paradigm for clinical operations.
Promoter: Dassault Systèmes, the 3DEXPERIENCE Company and Medidata
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We providebusiness and people with collaborative virtual environments to imagine sustainable innovations. Bycreating ‘virtual twin experiences’ of the real world with our 3DEXPERIENCE platform andapplications, our customers push the boundaries of innovation, learning and production. Powered bythe 3DEXPERIENCE® platform, BIOVIA™ provides global, collaborative product lifecycle experiencesto transform scientific innovation. Website: https://www.3ds.com/it/
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients.Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical deviceand diagnostics companies, and academic researchers accelerate value, minimize risk, and optimizeoutcomes. More than one million registered users across 1,900+ customers and partners access theworld’s most trusted platform for clinical development, commercial, and real-world data. Medidata, aDassault Systèmes company. Discover more at www.medidata.com
and follow us @Medidata.